Global /United States /Healthcare /Medical Distribution /MCK
chevron_leftBack
McKesson Corp. logo

McKesson Corp.

MCK
NYSE: MCK Delayed
822.63USD -1.5%
As of 11 July 2026, McKesson Corp. has a market cap of $100.76B USD, ranking #216 globally and #108 in the United States. It ranks #25 in the Healthcare sector, and #1 in the Medical Distribution industry.
Global Rank
216
1d: 0
1w: +1
1m: -
Country Rank
108
1d: 0
1w: 0
1m: -
Sector Rank
25
1d: 0
1w: 0
1m: -
Industry Rank
1
1d: 0
1w: 0
1m: -
Key Stats
Market Cap
$100.76BUSD
Enterprise Value
$106.79BUSD
Revenue (TTM)
$397.96BUSD
EBITDA (TTM)
$5.93BUSD
Net Income (TTM)
$4.34BUSD
EBITDA Margin
1.5%
Profit Margin
1.1%
PE Ratio
24.0
Forward PE
19.3
PS Ratio
0.3
EV/EBITDA
18.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Brian Tyler open_in_new
Employees
51,000
Founded
1833
Website
mckesson.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.5% -0.8% -4.4% -0.5% 2.2% 18%

News

Loading...

MCK Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
MCK
McKesson Corp
ISIN: US58155Q1031
Shares Out.:
117.078M1 Shares Float: 117.013M2
TV:
SA:
YF:
MCK
GF:
NQ:
MCK
BA:
MCK
MS:
822.63 USD
London Stock Exchange
MIC: XLON
0JZU
McKesson Corp
ISIN: US58155Q1031
TV:
SA:
YF:
GF:
BA:
MS:
829.64 USD
Borsa Italiana
MIC: XMIL
1MCK
McKesson Corp
ISIN: US58155Q1031
TV:
SA:
YF:
GF:
BA:
MS:
819.20 EUR
Show all 7 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About McKesson Corp.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Similar Companies

Industry: Medical Distribution (United States)
Name
Market Cap diff.
PE
COR
$60.58B
-40%
37.4
$47.73B
-53%
29.6
HSIC
$8.47B
-92%
22.6
OLPX
$1.37B
-99%
-
$266.77M
-100%
-
YJGJ
$40.27M
-100%
46.7
Industry: Medical Distribution (Global)
Name
Market Cap diff.
PE
$7.48B
58.61B HKD
-93%
7.2
GALE
$5.21B
4.2B CHF
-95%
23.0
DKSH
$4.75B
3.83B CHF
-95%
18.9
$3.81B
25.88B CNY
-96%
13.3
4164
$3.65B
13.7B SAR
-96%
16.5
$3.56B
577.66B JPY
-96%
14.1
chevron_leftBack